Form D · Biotechnology
Mati Therapeutics Inc.
Austin, TX · CIK 0001574251
Offering snapshot reported Jul 2, 2026 · SEC filing
- Reported sold
- $2.65M Offering amount: $4.9M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 12, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,184,175 → $2,649,815
- Reported investors1 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2026 | Amendment | $2,649,815 | $465,640vs Sep 23, 2025 | 2 | SEC filing |
| Oct 8, 2025 | Initial | $9,867,695 | No comparison | 13 | SEC filing |
| Sep 23, 2025 | Initial | $2,184,175 | No comparison | 1 | SEC filing |
| May 24, 2019 | Initial | $165,030 | No comparison | 2 | SEC filing |
| Oct 16, 2018 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Oct 10, 2014 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Apr 15, 2013 | Initial | $1,310,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558333
Revenue Share
Source: Form D, filed Jul 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Butchofsky | Director, Executive |
| Robert Lee Butchofsky Ii | Director, Executive |
| Dave Fellows | Director |
| Ken Jones | Director |
| Linda Lupini | Director |
| Jim Mazzo | Director |
| Peter Mc Donnell | Director |
| Christopher Muller | Director, Executive |
| Chris Muller | Director, Executive |
| Cameron Nelson | Executive |
| Joseph Tortorice Iii | Director |
| Deepank Utkede | Director, Executive |
| Deepank Utkhede | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Austin, TX, 78701
Phone: 512-720-1333